Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-02-13
2010-11-09
Monshipouri, Maryam (Department: 1656)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S300000, C530S350000
Reexamination Certificate
active
07829523
ABSTRACT:
Methionine is an effective antioxidant for polypeptides having an amino acid sequence lacking methionine. Compositions containing polypeptides having an amino acid sequence that is free of methionine residues are stabilized from oxidative degradation by combining methionine in the composition in an amount effective to inhibit oxidation of the polypeptide.
REFERENCES:
patent: 5272135 (1993-12-01), Takruri
patent: 5358708 (1994-10-01), Patel
patent: 5837838 (1998-11-01), Reed
patent: 6525102 (2003-02-01), Chen
patent: 6734162 (2004-05-01), Van Antwerp et al.
patent: 2003/0103895 (2003-06-01), Cyr
Baggiolini, M., et al. 1989 J Clin Invest 84: 1045-1049.
Levine, R.L. et al. 1999 Mechanisms of Ageing and Development 107: 323-332.
Rothstein, et al, “Anticandida activity is retained in P-113, a 12-amino-acid fragment of Histatin 5”, Antimicrobial Agents and Chemotherapy, 45(5):1387-1373 (2001).
Mayhew James
Wagner Hali
Dow Pharmaceutical Sciences
Eisenberg, Esq. Howard
Monshipouri Maryam
Tsay Marsha M
LandOfFree
Method for stabilizing polypeptides lacking methionine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for stabilizing polypeptides lacking methionine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for stabilizing polypeptides lacking methionine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4211595